Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 11/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 9/20 | 0.42 |
| ▸ | ITK | Q08881 | 2/20 | 0.42 |
| ▸ | PAK4 | O96013 | 3/20 | 0.42 |
| ▸ | PLK4 | O00444 | 3/20 | 0.42 |
| ▸ | RET | P07949 | 4/20 | 0.40 |
| ▸ | JAK2 | O60674 | 5/20 | 0.39 |
| ▸ | JAK3 | P52333 | 5/20 | 0.39 |
| ▸ | TYK2 | P29597 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | JAK1 | P23458 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.39 |
| ▸ | GSK3B | P49841 | 8/20 | 0.39 |
| ▸ | SRC | P12931 | 6/20 | 0.39 |
| ▸ | GSK3A | P49840 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10122947 | 0.75 | AURKA (0.61) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL4421488 | 0.73 | ITK (0.44) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL12430966 | 0.72 | AURKA (0.48) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL12430965 | 0.72 | AURKA (0.47) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL3993234 | 0.72 | PAK4 (0.49) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL4428986 | 0.71 | ITK (0.42) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL12430978 | 0.70 | PAK4 (0.43) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL802004 | 0.69 | ITK (0.50) | AURKAAURKBITKRETNTRK1 | |
| SCHEMBL13097638 | 0.69 | DHODH (0.48) | AURKAAURKBITKPAK4PLK4 | |
| SCHEMBL13840507 | 0.68 | AURKA (0.49) | AURKAAURKBPAK4PLK4GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030004161-A1 | Pyrazole compounds useful as protein kinase inhititors | VERTEX PHARMACEUTICALS INCORPORATED | 2003-01-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004161-A1 | Pyrazole compounds useful as protein kinase inhititors | AURKC, AURKA, GSKIP | AURKA 2/4885AURKB 6/4885ITK 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.